The Oklahoma marijuana legalization initiative gets crushed at the polls, a bipartisan federal bill to ease the rescheduling of therapeutic psychedelics gets filed, and more.

Delaware House Approves Marijuana Legalization Bill; Marijuana Regulation Bill Pending. The House on Tuesday gave final approval to House Bill 1, which legalizes the possession of up to an ounce by adults. Bill sponsor Rep. Ed Osienski (D) is also sponsoring House Bill 2, which would set up a regulatory system for marijuana commerce. That bill has passed out of committee and is awaiting a House floor vote. Last year, Osienski took a similar bifurcated path, with the legalization bill passing but the regulatory bill failing. Gov. John Carney (D) then vetoed the legalization bill. This year, the legalization bill passed with a veto proof majority.

Hawaii Senate Approves Marijuana Legalization Bill. The Senate voted overwhelmingly Tuesday to approve a marijuana legalization bill, Senate Bill 669. The bill would legalize the possession of up to 30 grams, allow for the home cultivation of up to six plants, expunge past possession convictions, and reduce penalties for unlicensed cultivation and sales. The bill also contemplates the existing medical marijuana industry morphing into a full-fledged adult use marijuana market under the aegis of a Hawaii Cannabis Authority. The bill is now before the House.

Oklahoma Marijuana Legalization Initiative Defeated. Voters on Tuesday decisively defeated a marijuana legalization initiative, State Question 820 by a margin of 62 percent to 38 percent. See out feature story later today for full coverage.

Psychedelics-                                                                                          

Bipartisan "Breakthrough Therapies Act" Updated and Filed. Sens. Rand Paul (R-KY) and Cory Booker (D-NJ) and Reps. Madeleine Dean (D-PA) and Nancy Mace (R-SC) on Thursday filed the "Breakthrough Therapies Act," which would streamline the federal rescheduling of drugs such as psilocybin and MDMA for therapeutic purposes. The bill would amend the Controlled Substance Act to create a pathway for current Schedule I drugs that could be deemed breakthrough therapies by the Food and Drug Administration (FDA) to qualify for a waiver under the Food, Drug, and Cosmetic Act and be moved to Schedule II, which is reserved for drugs with "currently accepted medical use with severe restrictions."

Missouri Therapeutic Psychedelic Bill Advances. The House Veterans Committee on Tuesday approved House Bill 1154, which would promote research into the therapeutic potential of psychedelics such as ketamine, MDMA, and psilocybin. The bill passed out of committee on a unanimous vote. The bill now awaits a possible House floor vote, which is yet to be scheduled.

Foreign Policy

.Reps. Dan Crenshaw (R-TX) and Tim Walz (R-FL) on Monday filed a resolution, HJ Res. 18 "to authorize the use of United States Armed Forces against those responsible for trafficking fentanyl or a fentanyl-related substance into the United States or carrying out other related activities that cause regional destabilization in the Western Hemisphere." The resolution is cutely titled "Authorization for the Use of Military Force to Combat, Attack, Resist, Target, Eliminate, and Limit Influence Resolution" or the "AUMF CARTEL Influence Resolution." The bill specifically lists nine Mexican drug trafficking organization to be targeted, including the Sinaloa Cartel, the Jalisco New Generation Cartel, the Gulf Cartel, and Los Zetas. 

Shielded: How the Police Became Unaccountable by Joanna Schwartz (2023: Viking Press, 308 pp., $30 HB)

As Donald Trump laid out his fascistoid law and order platform last month, he vowed to bring back stop-and-frisk, railed against "radical Marxist prosecutors," warned of civil rights investigations of "radical leftist prosecutors" for alleged race-based policing, and promised the death penalty for drug dealers, among other fearsome fulminations. But the first bullet point of his manifesto regarded cops: Not only would he fund record hiring levels; he would also "increase vital liability protection for America's law enforcement."

With that pledge, the not-yet-indicted former president played to longstanding but unproven concerns that citizens' ability to seek civil redress for police mistreatment under civil rights laws would force police officers into bankruptcy if they were found liable for heat-of-the-moment lapses. Equally to be feared -- and equally unproven -- is the notion that being able to hold police liable will inhibit them from fully exercising their crime-fighting powers and protecting public safety.

Not to worry, officer! As UCLA law professor Joanna Schwarz makes clear in Shielded, her new book on (the lack of) police accountability, cops get away with murder. And rape. And torture. And beatings. And various other forms of street-tough thuggery. Schwartz has spent years researching how our legal system protects police at all costs through the accretion over decades of Supreme Court decisions interpreted by a non-representative federal bench with cases tried by juries filled with people who have never had a bad encounter with police. (In federal civil cases, felons cannot be jurors, and the voir dire process eliminates potential jurors with negative perceptions of law enforcement.)

Over the course of decades, the Supreme Court first opened the door to civil rights litigation to address police violation of constitutional rights, then, in case after case, effectively pushed it back until it is now barely open a crack. It is no accident that this has occurred under a Supreme Court that has been sliding to the right for the last 50 years and is now the most reactionary court in a century. One technique is to require plaintiffs to show sufficient evidence of patterns of police misconduct before they are allowed to undertake discovery, the process by which both sides in a case are allowed to see and seek relevant evidence. In the case of rogue police departments, this would be records of officer infractions, incident reports, and the like. But under current Supreme Court precedent, federal judges summarily dismiss cases before discovery because plaintiffs have not produced the evidence they have not yet been allowed to seek. That's a hell of a Catch-22.

Another huge hurdle in front of people seeking redress for police misconduct is qualified immunity, a notion constructed out of thin air by the Supreme Court in 1967 and turned into another Catch-22 by the Supreme Court in 1982. Qualified immunity is a defense to civil rights claims that is granted if the law the cop violated is not "clearly established," and if qualified immunity applies, plaintiffs cannot collect monetary damages. Under the 1982 decision, the federal courts find that qualified immunity applies unless the plaintiff can show a previous case with the exact same facts has been decided in federal court.

But Schwartz shows that the Supreme Court is only one of the "shields" protecting police. At the institutional level, police Internal Affairs bureaus generally do not punish nor track misbehavior. At the municipal level, budgets anticipate having to pay out damages for police behavior, with the taxpayers—not the miscreant officers—paying up. At the state level, legislators pass laws that further protect police. And there are more obstacles that Schwartz elucidates, from the makeup of the federal judiciary and federal juries to financial disincentives for attorneys to spend their careers litigating civil rights cases where they could spend thousands of hours preparing cases only to have them settled and end up being paid a pittance for their efforts.

This is not a book about the war on drugs, but the war on drugs is implicated throughout.  Many, many of the encounters between police and citizens that result in civil rights violation complaints arise from the prosecution of the drug war, and many, many of the victims are drug users or suspected drug users.

Schwartz lucidly and cogently explores the mountain of obstacles people seeking justice for police mistreatment face, as well as the obstacles facing people who want to remake the system into something nearer to common notions of justice. Given the current makeup of the Supreme Court and the stalemated state of play in Congress, relief is unlikely to come from the federal government. The problem seems intractable.

But Schwartz sees opportunities for positive change at the state and local levels, and she cites Colorado's 2020 passage of a bill ending qualified immunity, requiring officers found to have operated in bad faith to pay something out of their own pockets (as opposed to being indemnified by the city or state, which pays the judgement), and allows plaintiff attorneys to recover their fees when they prevail.

This is an important, eye-opening work. If you are concerned about who will guard us from the guardians (and how), it is indispensable.

Four federal legislators file a bill to strengthen the drug war in the Caribbean, a Hawaii bill to ease the way toward the therapeutic use of psilocybin and MDMA passes the Senate, and more.

Marijuana Policy

Minnesota Marijuana Legalization Bill Wins More Committee Votes. The effort to legalize marijuana continued to bear fruit this week, with the House version of the bill, House File 100 being approved Monday by the House Human Services Policy Committee and the companion Senate bill being approved that sa me day by the Senate Transportation Committee. The actions mark the eighth approval by a House committee and the sixth by a Senate committee. With majorities in the House and Senate, as well as control of the governorship, the Democratic-Farmer-Labor Party is confident the bill will become law this year. It looks like there are only four committee votes to go before the bill heads for floor votes in the two chambers.

Opiates and Opioids

Idaho Bill Would Lower Heroin Penalties, Create Mandatory Minimums for Dealing Fentanyl. A bill before the legislature, House Bill 67, would raise quantity thresholds and reduce sentences for heroin dealing while creating a mandatory minimum sentence for fentanyl dealing. The amount of heroin required for a trafficking charge would jump from two grams to seven in the bottom tier and from 10 to 14 grams in the middle tier. Sentences for the top tier of heroin trafficking offenses would drop from 15 years to 10 and sentences for the middle tier would drop from 10 years to five. The bill would also make possession of more than seven grams of fentanyl a felony chargeable as "trafficking." Those caught with more than seven grams would face a three-year mandatory minimum, while those caught with more than 14 grams would face a five-year mandatory minimum, and those caught with more than 28 grams would face a 10-year mandatory minimum. The Idaho Chiefs of Police, Idaho Sheriffs Association and the Idaho Prosecuting Attorneys Association are all in favor of House Bill 67.

Psychedelics

Hawaii Psilocybin and MDMA Research Bill Wins Committee Vote. The Senate Health and Human Services Committee has approved Senate Bill 1531, which is aimed at promoting research into the therapeutic uses of MDMA, psilocybin, and other alternative mental health treatments. The bill would create a Beneficial Treatments Advisory Council that would review the scientific literature on using such substances for mental health treatment as well as exploring state and federal regulations on them. The council would be required to develop a "long-term strategic plan to ensure the availability of therapeutic psilocybin, psilocybin-based products, and [MDMA] that are safe, accessible, and affordable for adults twenty—one years of age or older." A companion bill in the House has yet to move.

Drug Policy

Old School Prohibitionist Bill to Fight Caribbean Drug Trafficking Filed in Congress. On Monday, three Republicans and one Democrat, Sens. Rick Scott (R-FL) and Alex Padilla (D-CA) and Reps. Jenniffer González-Colon (R-PR) and Stacey Plaskett (R-VI) introduced the Caribbean Border Counternarcotics Strategy Act , which aims "to stop the illegal trafficking of deadly drugs in the Caribbean, specifically between Puerto Rico, the US Virgin Islands and Florida." The bill would "ensure the Federal government has a strategy in place to prevent the flow of illicit drugs through the Caribbean region and into the United States by codifying in statute the requirement for ONDCP to issue a Caribbean Border Counternarcotics Strategy—just as Congress has codified the requirement for the Southwest Border and the Northern Border Counternarcotics Strategies." It would also clarify that US territories are included in the definition of "state" and "United States." 

International

Colombian Government in Peace Talks with Leftist Rebels Who Demand "Alternative Drug Policies." The government of President Gustavo Petro and the country's largest remaining rebel group met in Mexico City to restart peace talks aimed at resolving a conflict dating back to the 1960s. The communist-inspired National Liberation Army (ELN) is calling for a "temporary, nationwide cease-fire" and that any agreement should include "an alternative anti-drug policy that is no longer based on repression and war." The ELN has a presence in some 200 Colombian township, mostly in areas of widespread coca cultivation and cocaine production. Like the larger FARC, which signed a peace agreement with the state in 2016, the ELN is involved in the drug trade and has replaced the FARC in many areas. But even though it is involved in the drug traffic, the ELN is adamant that it should not be treated like a drug trafficking organization but as a political force. This is the second round of talks since Petro took office last year. The first round did not achieve much. 

Legal adult marijuana sales have commenced in Missouri, the Maryland legislature is moving to pass bills to set up a system of taxed and regulated legal marijuana commerce, and more.

Marijuana Policy.

Federal Judge Rules Ban on Marijuana Users Owning Guns Unconstitutional. Citing last year's US Supreme Court ruling expanding gun rights, a federal judge in Oklahoma has ruled that a federal law barring marijuana users from owning guns is unconstitutional. US District Court Judge Patrick Wyrick threw out an indictment of a ban charged with violating that ban, saying it infringed on his 2nd Amendment rights. While the federal government can protect the public from dangerous people owning guns, it could not argue that the man's "mere status as a user of marijuana justifies stripping him of his fundamental right to possess a firearm," Wyrick held, adding that using marijuana was "not in and of itself a violent, forceful, or threatening act."The Justice Department has not said whether it will appeal the ruling. This is just the latest decision to expand gun rights after the Supreme Court's conservative majority ruled in June that the 2nd Amendment protects a person's right to carry a handgun in public. Just a day earlier than this case's ruling last Friday, an appeals court in New Orleans found unconstitutional a federal law barring people with domestic violence restraining orders from owning guns.

Senate Democrats Look for Way to Move Forward on Marijuana Banking Bill. Just weeks after an effort to pass marijuana banking legislation died at the end of the last session, Senate Majority Leader Chuck Schumer (D-NY) met with several other key Democrats last week to "ponder the path" to passage in this Congress, Sen. Jeff Merkley (D-OR) said. "Hopefully we can find a formulation and have bipartisan support and get it done." Also meeting with Schumer and Merkley were Sens. Sherrod Brown (D-OH), Cory Booker (D-NJ), and Jackie Rosen (D-NV). But while the Democrats still control the Senate, Republicans now control the House, complicating the prospects for progress on the issue.

Maryland Lawmakers Roll Out Bill to Launch Marijuana Sales. Lawmakers in both the House and Senate rolled out identical bills to tax and regulate legal marijuana commerce last Friday. The move comes after voters approved a marijuana legalization referendum on last November's ballot. House Bill 566 and Senate Bill 516 set a tax rate of six percent for the first fiscal year, which would increase by one percent a year until reaching 10 percent in 2028. Thirty percent of those revenues would go to a community reinvestment fund for at least the next decade, with another 1.5 percent going to localities. The bills also include an Office of Social Equity to promote participation in the industry by people impacted by marijuana prohibition. Lawmakers are aiming to launch legal sales by July 1, but there is still a lot of work to between here and there.

Missouri Legal Marijuana Sales Have Begun. That didn't take long. Voters approved marijuana legalization last November, and the first legal sales came last Friday. The first sales came at already existing medical marijuana dispensaries that had upgraded their licenses to include adult sales, and opening day crowds were sizeable at stores such as Good Day Farm, Fresh Green Dispensary, and Greenlight, among others. State officials previously said that 318 of 322 licensed dispensaries had applied to convert to adult sales licenses.

International

 

. In a surprise decision, the federal government's Therapeutic Goods Administration (TGA) has approved the use of the psychedelic substances in magic mushrooms and MDMA for people with certain mental health conditions. MDMA and psilocybin, the active ingredient in magic mushrooms, are now considered Schedule 8 drugs, meaning they can be prescribed by a psychiatrist for controlled use. MDMA will be used to treat post-traumatic stress disorder, while psilocybin is approved for treatment-resistant depression. They will still be considered prohibited substances (Schedule 9 drugs) for all other purposes. "Prescribing will be limited to psychiatrists, given their specialized qualifications and expertise to diagnose and treat patients with serious mental health conditions,"a TGA statement published on Friday said.

But the TGA has not yet approved any products containing MDMA or psilocybin, so psychiatrists will have to obtain and supply unapproved medicines for the specific authorized uses. There is also a dearth of qualified psychiatrists, said Stephen Bright, director of the Psychedelic Research in Science and Medicine NGO. "The details so far from the TGA are thin. There are no products available, and aside from myself and a handful of colleagues, there’s no-one trained to provide the treatment. We’re waiting for a bit more information, to get an idea of what this looks like in practice," he said.